Add to ORKGPOLITICO Studio speaks with Ricardo Marek, President Europe and Canada at Takeda Pharmaceuticals, on why rare diseases need to be a public health priority, and how Europe can remain a leader in life sciences
Global Health has not featured as prominently in the European Union (EU) research agenda in recent y...
to strengthen and improve European medical research, which in turn will result in better healthcare ...
Today, cancer is a significant challenge for society, healthcare systems and the growing number of a...
POLITICO Studio speaks with Ricardo Marek, President Europe and Canada at Takeda Pharmaceuticals, on...
Rare diseases (RDs) are defined by the European Union as life-threatening or chronically debilitati...
AbstractRare diseases are those with a particularly low prevalence; in Europe, diseases are consider...
Biotechnology and the life sciences promise to revolutionise societies, notably by curing terrible d...
Whilst European leaders and the EU institutions are currently focused on firefighting the economic, ...
Europeans have never been healthier than they are today. Yet although European countries have experi...
This marks a remarkable milestone when the serendipity-mindsponge-3D knowledge management theory is ...
From the current refugee crisis to ageing populations, and from rising healthcare prices to patients...
Medicine and healthcare are undergoing profound changes. Whole-genome sequencing and high-resolution...
In the past decade, Europe has experienced a positive trend of increased life expectancy. And yet th...
European health systems face growing, common challenges: the increasing cost of healthcare; an agein...
The Juncker Presidency came to an end two months ago, giving experts the chance to analyse the achie...
Global Health has not featured as prominently in the European Union (EU) research agenda in recent y...
to strengthen and improve European medical research, which in turn will result in better healthcare ...
Today, cancer is a significant challenge for society, healthcare systems and the growing number of a...
POLITICO Studio speaks with Ricardo Marek, President Europe and Canada at Takeda Pharmaceuticals, on...
Rare diseases (RDs) are defined by the European Union as life-threatening or chronically debilitati...
AbstractRare diseases are those with a particularly low prevalence; in Europe, diseases are consider...
Biotechnology and the life sciences promise to revolutionise societies, notably by curing terrible d...
Whilst European leaders and the EU institutions are currently focused on firefighting the economic, ...
Europeans have never been healthier than they are today. Yet although European countries have experi...
This marks a remarkable milestone when the serendipity-mindsponge-3D knowledge management theory is ...
From the current refugee crisis to ageing populations, and from rising healthcare prices to patients...
Medicine and healthcare are undergoing profound changes. Whole-genome sequencing and high-resolution...
In the past decade, Europe has experienced a positive trend of increased life expectancy. And yet th...
European health systems face growing, common challenges: the increasing cost of healthcare; an agein...
The Juncker Presidency came to an end two months ago, giving experts the chance to analyse the achie...
Global Health has not featured as prominently in the European Union (EU) research agenda in recent y...
to strengthen and improve European medical research, which in turn will result in better healthcare ...
Today, cancer is a significant challenge for society, healthcare systems and the growing number of a...